These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3930898)

  • 21. Increased bronchoalveolar IgG-secreting cells in interstitial lung diseases.
    Lawrence EC; Martin RR; Blaese RM; Teague RB; Awe RJ; Wilson RK; Deaton WJ; Bloom K; Greenberg SD; Stevens PM
    N Engl J Med; 1980 May; 302(21):1186-8. PubMed ID: 7366658
    [No Abstract]   [Full Text] [Related]  

  • 22. Surfactant protein B in type II pneumocytes and intra-alveolar surfactant forms of human lungs.
    Brasch F; Johnen G; Winn-Brasch A; Guttentag SH; Schmiedl A; Kapp N; Suzuki Y; Müller KM; Richter J; Hawgood S; Ochs M
    Am J Respir Cell Mol Biol; 2004 Apr; 30(4):449-58. PubMed ID: 12972403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Interstitial lung diseases. I. Pathomorphological and immunological aspects and the methods of studies].
    Hajduk B; Małecka G; Derentowicz P; Roszkowski W
    Pneumonol Pol; 1990; 58(4-5):263-8. PubMed ID: 2144046
    [No Abstract]   [Full Text] [Related]  

  • 24. Human lung lavage surfactant enhances staphylococcal phagocytosis by alveolar macrophages.
    O'Neill SJ; Lesperance E; Klass DJ
    Am Rev Respir Dis; 1984 Dec; 130(6):1177-9. PubMed ID: 6548882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pulmonary corpora amylacea contain surfactant apoprotein.
    Akino T; Mizumoto M; Shimizu H; Kuroki Y; Dempo K; Tsuda T; Yanai S; Mizuki M
    Pathol Res Pract; 1990 Oct; 186(5):687-91; discussion 691-5. PubMed ID: 2287594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal antibodies to surface antigens of rabbit type II pneumocytes.
    Fraser CM; Venter JC; Finkelstein JN; Shapiro DL
    Am Rev Respir Dis; 1984 Sep; 130(3):505-7. PubMed ID: 6383157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation and characterization of monoclonal antibodies to alveolar type II cell lamellar body membrane.
    Zen K; Notarfrancesco K; Oorschot V; Slot JW; Fisher AB; Shuman H
    Am J Physiol; 1998 Jul; 275(1):L172-83. PubMed ID: 9688949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relapsing poly(peri)chondritis associated with fibrosing alveolar disease and antibodies to pneumocytes type II and Clara cells.
    Rauh G; Dörfler H; Erlinger R; Riedel KG; Zöllner N
    Klin Wochenschr; 1989 Aug; 67(15):784-9. PubMed ID: 2671478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repopulation of a human alveolar matrix by adult rat type II pneumocytes in vitro. A novel system for type II pneumocyte culture.
    Lwebuga-Mukasa JS; Ingbar DH; Madri JA
    Exp Cell Res; 1986 Feb; 162(2):423-35. PubMed ID: 3510880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunochemical studies of the protein fraction of pulmonary surface active material.
    Klass DJ
    Am Rev Respir Dis; 1973 May; 107(5):784-9. PubMed ID: 4121152
    [No Abstract]   [Full Text] [Related]  

  • 31. Pulmonary surfactant as a physiologic immunosuppressive agent.
    Rich EA
    J Lab Clin Med; 1990 Jul; 116(1):4-5. PubMed ID: 2376695
    [No Abstract]   [Full Text] [Related]  

  • 32. UIP, DIP, and all that.
    Fishman AP
    N Engl J Med; 1978 Apr; 298(15):843-5. PubMed ID: 634319
    [No Abstract]   [Full Text] [Related]  

  • 33. The alveolar type II cells as a model for investigating the metabolism of surfactant phospholipids.
    Anceschi MM
    Eur Respir J Suppl; 1989 Mar; 3():10s-12s. PubMed ID: 2742680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Secretion of surfactant from type II pneumocytes. Protracted maturation of the secretory process--role of purinergic stimulation].
    Griese M
    Fortschr Med; 1995 Mar; 113(8):114. PubMed ID: 7759035
    [No Abstract]   [Full Text] [Related]  

  • 35. Surfactant treatment effects on alveolar type II cell morphology in rabbit lungs.
    Pinkerton KE; Lewis J; Mulder AM; Ikegami M; Jobe AH
    J Appl Physiol (1985); 1993 Mar; 74(3):1240-7. PubMed ID: 8482664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Temporal evolution of epithelial, vascular and interstitial lung injury in an experimental model of idiopathic pulmonary fibrosis induced by butyl-hydroxytoluene.
    Parra ER; Boufelli G; Bertanha F; Samorano Lde P; Aguiar AC; Costa FM; Capelozzi VL; Barbas-Filho JV
    Int J Exp Pathol; 2008 Oct; 89(5):350-7. PubMed ID: 18808527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Monoclonal antibodies against human pulmonary surfactant apoproteins in clinical and pathological diagnosis].
    Akino T; Kuroki Y; Takahashi H; Dempo K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1985 Dec; 23(12):1402-5. PubMed ID: 3841680
    [No Abstract]   [Full Text] [Related]  

  • 38. [The effects of surfactant-TA on bleomycin-induced lung injury and lung fibroblast proliferation].
    Ito M; Suwabe A; Suzuki T; Tominaga M; Takahashi K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Nov; 35(11):1163-72. PubMed ID: 9493441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ABCA3 is a lamellar body membrane protein in human lung alveolar type II cells.
    Yamano G; Funahashi H; Kawanami O; Zhao LX; Ban N; Uchida Y; Morohoshi T; Ogawa J; Shioda S; Inagaki N
    FEBS Lett; 2001 Nov; 508(2):221-5. PubMed ID: 11718719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical study of lung adenocarcinoma using monoclonal antibody for 60-kilodalton antigen in type II pneumocytes and nonciliated bronchiolar epithelial cells. Comparison with two antisurfactant apoprotein antibodies.
    Suehiro T; Maeda K; Sueishi K
    Am J Clin Pathol; 1989 Aug; 92(2):150-8. PubMed ID: 2547307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.